Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Compliance Office Wants To Find Clinical Trial Problems In Time To Correct Them

Executive Summary

The agency is seeking a quality-by-design approach to clinical trials so sponsors can identify potential risks to patient safety and trial implementation up-front and take steps to avoid them.

You may also be interested in...

Clinical Trial Monitoring Not Ready To Go Completely Off-Site, FDA Says

Agency yields to some, denies other industry requests in final guidance that declines to lay out one prescriptive monitoring path.

FDA Urges Centralized Clinical Trial Monitoring Over Frequent On-Site Visits - Guidance

Recent Duke University survey found that firms predominately conduct frequent visits to each clinical investigator site but "the rationale behind any specific monitoring approach does not appear to be evidence-based."

Public/Private Initiative To Help FDA Modernize Guidance For Clinical Trials

Output from the Clinical Trials Transformation Initiative, whose executive board was named May 5, is expected to lead to new FDA clinical trial guidance


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts